Deanna Russell
4PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 13, 2024
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial.Benjamin Besse, Elvire Pons-Tostivint, Keunchil Park
|Aug 31, 2022
Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors.Emerson A Lim, Johanna C Bendell, Gerald S Falchook
|Sep 18, 2020
STAT3 Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti-PD-L1.Theresa A Proia, Maneesh Singh, Richard Woessner
|Jan 19, 2020
Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response.Ben Sidders, Pei Zhang, Kelly Goodwin
Pageof 1
Frequent Collaborators
2 joint publications
Simon T Barry
2 joint publications
Rakesh Kumar
1 joint publications
Bolan Linghu
1 joint publications
Emerson A Lim
1 joint publications
Johanna C Bendell
1 joint publications
Gerald S Falchook
1 joint publications
Todd M Bauer
1 joint publications
Charles G Drake
1 joint publications
Deanna A Mele
1 joint publications
Daniel J George
